Biotech

All Articles

Biogen containers SAGE-324 partnership after important trembling fail

.Biogen has actually carried out the final ceremonies to its own collaboration with Sage Therapies o...

AbbVie Parkinson's medicine from $8.7 B Cerevel buyout scores

.On the same time that some Parkinson's illness medicines are being actually questioned, AbbVie has ...

Arch shuts $3B-plus fund to nurture biopharma startups

.On the heels of a $3 billion fund from Bain Funds Life Sciences, Arc Venture Allies is proving it c...

Orion to use Aitia's 'digital identical twins' to discover brand-new cancer cells medications

.Finnish biotech Orion has snooped possible in Aitia's "electronic twin" tech to build brand-new can...

Windtree's surprise med rears blood pressure in most up-to-date period 2 win

.While Windtree Therapies has actually battled to expand the monetary roots needed to make it throug...

2 cancer biotechs merge, creating international impact

.OncoC4 is taking AcroImmune-- and also its in-house clinical manufacturing functionalities-- under ...

Amgen reports initial phase 3 win for $400M chronic eczema drug

.Amgen has actually discussed (PDF) the 1st period 3 records on its own $400 million eczema medicati...

Biogen, UCB record period 3 lupus gain after falling short earlier test

.Biogen as well as UCB's gamble on developing in to phase 3 astride an unsuccessful study seeks to h...

Aptadir hopes brand new RNA preventions can reverse difficult cancers cells

.Italian biotech Aptadir Therapeutics has launched with the assurance that its own pipe of preclinic...

Wave surfs DMD excellence to regulators' doors, sending stockpile

.Wave Life Sciences has fulfilled its goal in a Duchenne muscular dystrophy (DMD) research study, in...